Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-02-29
1999-08-24
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514212, 514278, 514316, 514318, 514326, 514327, 514330, 514331, 540524, 540597, 540598, 546 16, 546186, 546187, 546189, 546190, 546191, 546208, A61K 31445, C07D21132, C07D24100
Patent
active
059425237
ABSTRACT:
A compound of formula: in which:
REFERENCES:
patent: 5236921 (1993-08-01), Emonds-Alt et al.
patent: 5340822 (1994-08-01), Emonds-Alt et al.
patent: 5576333 (1996-11-01), Miller
patent: 5674881 (1997-10-01), Emonds-Alt et al.
Maggi et al. "Tachykinin receptors and . . . " J. Auton. Pharmc. v.13, pp. 24, 50, 1993.
Kato et al. "Preparation and formulation of aryl sulfonamides . . . " CA 125:300606, 1996.
Bichon Daniel
Broeck Didier Van
Emonds-Alt Xavier
Gueule Patrick
Proietto Vincenzo
Chang Ceila
Sanofi
LandOfFree
Compounds which are selective antagonists of the human NK.sub.3 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds which are selective antagonists of the human NK.sub.3 , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds which are selective antagonists of the human NK.sub.3 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-467255